Product Details
Vandetanib for Tablets BP
Product Name
:
Vandetanib for Tablets BP
Brand Name
:
VERVAN-T
Available Strength
:
100 mg
Packing
:
30 Tablets
Pack Insert/Leaflet
:
According To Your Needs
These film-coated tablets meet British Pharmacopoeia standards, supporting targeted treatment for advanced medullary thyroid cancer. Oncologists prescribe Vandetanib under close supervision for patients with symptomatic or progressive disease.
Vandetanib BP (100 mg) is a multi-targeted tyrosine kinase inhibitor that blocks signaling pathways involved in tumor growth and blood vessel formation. As a result, it helps slow disease progression in eligible patients. Because Vandetanib carries a known cardiac safety consideration, oncology specialists prescribe it with regular monitoring as part of a carefully managed treatment plan. Therefore, hospitals and oncology clinics restrict its use to patients under close specialist supervision.
Key Features
- Meets BP (British Pharmacopoeia) standards for consistent quality
- Delivers targeted multi-kinase inhibition for thyroid cancer management
- Ensures accurate, validated dosing in every batch
- Manufactured under GMP-compliant, high-alert medication handling protocols
- Intended strictly for use under oncologist supervision with cardiac monitoring
- Restricted to hospital, oncology clinic, and specialist institutional supply